Prime Minister Gabriel Attal unveiled a plan to cut French jobless benefits in a bid to advance President Emmanuel Macron’s…
Investors’ worries around stubborn inflation and the timing of Federal Reserve rate cuts is resulting in rocky markets.While macro challenges…
A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the…
CFOTO | Future Publishing | Getty ImagesNvidia last week announced a 10-for-1 stock split which will bring its share price…
Stiglitz says the protest movement gripping his institution and many others “does hit home” and recalled his own history as…
Martin Gruenberg, chairman of the Federal Deposit Insurance Corporation (FDIC), during a House Financial Services Committee oversight hearing in Washington,…
Don’t make the mistake of patronizing the Ferrari 296 GTS. I know it’s tempting, because this $366,139 centerfold packs a…
Traders work on the floor of the New York Stock Exchange during morning trading on May 24, 2024 in New…
It’s the question many scientists are asking about the controversial drug, a glucagon-like peptide-1 receptor agonist (GLP-1), as some research…
Fatcamera | E+ | Getty ImagesTo understand why women are still fighting to catch up to men economically, author Josie…
Treasury Secretary Janet Yellen said the outlook for higher interest rates over the long haul makes it tougher to contain…
Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and…